- Home
- EZGO vs PASG Comparison
EZGO vs PASG Comparison
Compare EZGO & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EZGO | PASG |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | China | United States |
| Employees | N/A | 27 |
| Industry | Motor Vehicles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 26.0M |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | EZGO | PASG |
|---|---|---|
| Price | $1.60 | $5.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 83.1M | 64.6K |
| Earning Date | 07-01-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $0.35 |
| 52 Week High | $2.99 | $20.00 |
Technical Indicators
Market Signals| Indicator | EZGO | PASG |
|---|---|---|
| Relative Strength Index (RSI) | 59.09 | 42.65 |
| Support Level | $0.12 | $3.94 |
| Resistance Level | $2.22 | $5.74 |
| Average True Range (ATR) | 0.43 | 0.38 |
| MACD | 0.19 | 0.18 |
| Stochastic Oscillator | 54.32 | 69.53 |
Price Performance
Historical ComparisonAbout EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About PASG Passage Bio Inc.
Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.